Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies

By Ahmad S.   Haas S.   Hoppensteadt D.A.   Lietz H.   Reid U.   Bender N.   Messmore H.L.   Misselwitz F.   Bacher P.   Gaikwad B.S.   Jeske W.P.   Walenga J.M.   Fareed J.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite

Antibodies to Platelet Factor 4/Heparin are Associated with Elevated Endothelial Cell Activation Markers in Patients with Acute Coronary Ischemic Syndromes

By Mascelli Mary   Deliargyris Efthymios   Damaraju Lakshmi   Barnathan Elliot   Califf Robert   Simoons Maarten   Sane David  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 171-175

Springer Publishing Company

Access to resources Recommend Favorite

Platelet Count, Anti-Heparin/Platelet Factor 4 Antibodies and Tissue Factor Pathway Inhibitor Plasma Antigen Level in Chronic Dialysis - A study of 44 cases

By Luzzatto G.   Bertoli M.   Cella G.   Fabris F.   Zaia B.   Girolami A.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 115-122

Elsevier

Access to resources Recommend Favorite

Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia - The pathogenic role of IgG

By Untch B.   Ahmad S.   Jeske W.P.   Messmore H.L.   Hoppensteadt D.A.   Walenga J.M.   Lietz H.   Fareed J.  

Thrombosis Research, Vol. 105, Iss. 2, 2002-01 ,pp. : 117-123

Elsevier

Access to resources Recommend Favorite

Antiplatelet Factor 4-Heparin Antibodies in Patients with Antiphospholipid Antibodies - A hypothesis based on parallelisms with heparin-induced thrombocytopenia

By Martinuzzo M.E.   Forastiero R.R.   Adamczuk Y.   Pombo G.   Carreras L.O.  

Thrombosis Research, Vol. 95, Iss. 6, 1999-09 ,pp. : 271-279

Elsevier

Access to resources Recommend Favorite